Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

493
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
493
Cancer Survival Analysis01:21

Cancer Survival Analysis

844
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
844
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

317
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
317
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

985
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
985
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

719
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
719

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disrupted Causal Connectivity Anchored in the Posterior Cingulate Cortex in Amnestic Mild Cognitive Impairment.

Frontiers in neurology·2017
Same author

The Triple Functions of D2 Silencing in Treatment of Periapical Disease.

Journal of endodontics·2017
Same author

Excellent Thermoelectric Properties in monolayer WSe<sub>2</sub> Nanoribbons due to Ultralow Phonon Thermal Conductivity.

Scientific reports·2017
Same author

Activation of Akt by SC79 protects myocardiocytes from oxygen and glucose deprivation (OGD)/re-oxygenation.

Oncotarget·2017
Same author

ColorSketch: A Drawing Assistant for Generating Color Sketches from Photos.

IEEE computer graphics and applications·2017
Same author

Enclosure Transform for Interest Point Detection From Speckle Imagery.

IEEE transactions on medical imaging·2017
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
Same journal

A robust neural network with random effects for subject-specific prediction of clustered count data.

Statistical methods in medical research·2026
Same journal

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.

Statistical methods in medical research·2026
Same journal

Joint analysis of longitudinal and recurrent event data: A functional regression approach with autoregressive frailty.

Statistical methods in medical research·2026
See all related articles

Related Experiment Video

Updated: Apr 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K

Bayesian multivariate augmented Beta rectangular regression models for patient-reported outcomes and survival data.

Jue Wang1, Sheng Luo1

  • 1Department of Biostatistics, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Statistical Methods in Medical Research
|June 4, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical model for analyzing patient-reported outcomes (PROs) in longitudinal studies. The model accurately handles complex data, including outliers and patient dropouts, improving parameter estimation for Parkinson's disease research.

Keywords:
Augmented BetaBeta rectangular distributionBeta regressionMarkov chain Monte Carlolongitudinal dataproportional data

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.1K

Related Experiment Videos

Last Updated: Apr 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.1K

Area of Science:

  • Biostatistics
  • Longitudinal Data Analysis
  • Clinical Trials

Background:

  • Longitudinal studies often collect patient-reported outcomes (PROs) on a [0,1] scale.
  • These PROs can be correlated, contain boundary values (0 or 1), outliers, and heavy tails.
  • Terminal events like death or dropout may depend on these PROs.

Purpose of the Study:

  • To propose a novel joint modeling framework for analyzing longitudinal PROs and terminal events.
  • To address challenges including multiple correlated PROs, boundary values, outliers, heavy tails, and PRO-dependent terminal events.

Main Methods:

  • A multivariate augmented mixed-effects model using Beta rectangular distributions for longitudinal PROs.
  • A Cox model for terminal events, integrated within a joint modeling framework.
  • Simulation studies to compare the proposed model with existing Beta distribution-based models.

Main Results:

  • The proposed joint model demonstrated more accurate parameter estimates compared to standard Beta distribution models.
  • This accuracy was evident even with the presence of outliers, heavy tails, and PRO-dependent terminal events.
  • The model was successfully applied to Parkinson's disease patient data from the Long-term Study-1 (LS-1).

Conclusions:

  • The developed joint modeling framework effectively handles complex features of longitudinal PRO data.
  • The Beta rectangular distribution-based approach offers improved statistical accuracy for such data.
  • This methodology enhances the analysis of longitudinal PROs in clinical studies, particularly for diseases like Parkinson's.